About the Company
Odonate Therapeutics, Inc. is a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. Odonate’s initial focus is on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are widely used in the treatment of cancer. Odonate’s goal for tesetaxel is to develop an effective chemotherapy choice for patients that provides quality-of-life advantages over current alternatives.
|Name||Ticker||Market Capitalization (USD M)||Revenue (USD M)||Price/Book||Price/Earning||Net Margin (%)|
|Conversion Labs Inc||CVLB||108548||35213||3.74||42.66||7.33|
|Royalty Pharma plc||RPRX||18925||2239||2.81||15.20||43.40|
|Organon & Co.||OGN||8844||7891||-4.56||5.07||22.06|
|ATAI Life Sciences N.V.||ATAI||2272||20||4.78||-10.40||-932.88|
|Cronos Group Inc||CRON||2097||57||1.32||-14.52||-258.59|
|Usana Health Sciences Inc||USNA||2079||1254||4.73||14.98||11.09|
|NRX Pharmaceuticals Inc||NRXP||1170||2321||0.45||5.05||9.91|
|Phathom Pharmaceuticals Inc||PHAT||1033||7.01||-6.45||None|
|Intersect ENT Inc||XENT||893||103||21.65||-13.01||-66.55|
|Phibro Animal Health Corp.||PAHC||893||833||3.70||16.25||6.53|
|Edgewise Therapeutics Inc||EWTX||796||2.70||-29.55||None|
|Fulcrum Therapeutics Inc||FULC||711||15||8.62||-9.63||-481.07|
|Pliant Therapeutics Inc||PLRX||614||13||2.51||-7.16||-613.56|
|Cyteir Therapeutics Inc||CYT||596||3.20||-20.62||None|
|Urovant Sciences Ltd||UROV||503||-3.65||-3.08||None|
|Ikena Oncology Inc||IKNA||404||10||2.18||-7.38||-551.28|
|Provention Bio Inc||PRVB||377||2.53||-2.94||None|
|Rain Therapeutics Inc||RAIN||355||413||2.19||-11.66||123.20|
|Verrica Pharmaceuticals Inc||VRCA||325||12||6.57||-8.92||-301.45|
|Adicet Bio Inc||ACET||280||9||1.22||-4.97||-603.06|
|Terns Pharmaceuticals Inc||TERN||252||1.40||-7.30||None|
|Milestone Pharmaceuticals Inc||MIST||219||15||1.23||-7.37||-215.93|
|Kaleido Biosciences Inc||KLDO||184||1||4.11||-2.07||None|
|Citius Pharmaceuticals Inc||CTXR||179||2.24||-7.81||None|
|Aquestive Therapeutics Inc||AQST||142||42||-2.95||-2.21||-152.73|
|Eton Pharmaceuticals Inc||ETON||124||15||6.13||-10.10||-74.52|
|Osmotica Pharmaceuticals Plc||OSMT||122||190||2.37||-1.31||-47.85|
|Kala Pharmaceuticals Inc||KALA||119||11||1.53||-0.94||None|
|Xeris Biopharma Holdings Inc||XERS||111||34||12.19||-1.44||-248.46|
|Odonate Therapeutics Inc||ODT||110||1.39||-0.94||None|
|Anebulo Pharmaceuticals Inc||ANEB||102||7.93||-2.58||None|
|Opiant Pharmaceuticals Inc||OPNT||100||37||3.03||-96.15||-3.06|
|Aerpio Pharmaceuticals Inc||ARPO||99||15||2.98||-5.24||-28.77|
|Natural Alternatives Internati||NAII||80||179||1.07||7.90||6.03|
|India Globalization Capital In||IGC||67||0||2.45||-7.60||-981.18|
|VYNE Therapeutics Inc||VYNE||51||16||0.77||2.31||-554.66|
|Assertio Holdings Inc||ASRT||36||117||0.49||-0.63||-38.05|
|Dermata Therapeutics Inc||DRMA||36||-75.67||-7.32||None|
|Acasti Pharma Inc||ACST||33||0||1.43||-1.66||-611.47|
|Nabriva Therapeutics Plc||NBRV||29||12||0.88||-0.49||-452.55|
|Lexaria Bioscience Corp||LEXX||27||1||3.76||-6.95||-445.15|
|Bio-Path Holdings Inc||BPTH||26||0||1.19||-2.49||18.96|
|Reviva Pharmaceuticals Holding||RVPH||25||1.41||-4.08||None|
|Baudax Bio Inc||BXRX||25||1||-10.80||0.76||9.10|
|Trevi Therapeutics Inc||TRVI||23||1.64||-0.66||None|
|Timber Pharmaceuticals Inc||TMBR||20||0||8.75||0.67||-527.55|
|Hoth Therapeutics Inc||HOTH||19||1.64||-2.02||None|
|Sonoma Pharmaceuticals Inc.||SNOA||11||17||3.32||-2.16||-31.96|
There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ...
Looking at Odonate Therapeutics, Inc.'s (NASDAQ:ODT ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by ...
Odonate Therapeutics, Inc., formerly Odonate Therapeutics, LLC, is a pharmaceutical company. The Company is engaged in the development of therapeutics to improve and extend the lives of patients ...
Looking at Odonate Therapeutics, Inc.'s (NASDAQ:ODT ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders ...
NASDAQ: ODT Investor Notice: Update in Lawsuit against Odonate Therapeutics, Inc. announced by Shareholders Foundation
SAN DIEGO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces an update in the lawsuit that is pending for certain investors in Odonate Therapeutics, Inc. (NASDAQ: ODT) ...
SHAREHOLDER ALERT: Morris Kandinov Investigating ODT, AYTU, EAR, and CORT; Shareholders are Encouraged to Contact the Firm
SAN DIEGO, Sept. 08, 2021 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating the actions of the officers and board of directors of Odonate Therapeutics, Inc., Aytu Biopharma, Inc., ...
Series C (OCCIO) United States OOTC Closed-End Funds OFS Credit Co. Inc. 6.875% Cum. Redeem. Pfd. Series A (OCCIP) United States XNAS Closed-End Funds ...
Odonate Therapeutics, Inc. is a pharmaceutical company, which engages in the development of therapeutics that improves and extends the lives of patients with cancer. It focuses on the development ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...